A detailed history of Ambassador Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ambassador Advisors, LLC holds 643 shares of LLY stock, worth $511,615. This represents 0.1% of its overall portfolio holdings.

Number of Shares
643
Previous 612 5.07%
Holding current value
$511,615
Previous $554,000 2.71%
% of portfolio
0.1%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $23,936 - $29,760
31 Added 5.07%
643 $569,000
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $9,423 - $11,817
-13 Reduced 2.08%
612 $554,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $370,125 - $495,175
625 New
625 $486,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ambassador Advisors, LLC Portfolio

Follow Ambassador Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ambassador Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ambassador Advisors, LLC with notifications on news.